Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy

E-ISSN： 1873-5592|17|15|1773-1798

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.15, 2016-12, pp. : 1773-1798

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine

By Odeberg J.M. Kaufmann P. Kroon K.-G. Hoglund P.

European Journal of Pharmaceutical Sciences, Vol. 20, Iss. 4, 2003-12 ,pp. : 375-382

Elsevier

Access to resources Recommend Favorite

Prodrug Design to Improve Pharmacokinetic and Drug Delivery Properties: Challenges to the Discovery Scientists

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3874-3908

Bentham Science Publishers

Access to resources Recommend Favorite

Drug delivery systems: anticancer prodrugs and their polymeric conjugates

By Greenwald R.B.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite

Design for Optimized Topical Delivery: Prodrugs and a Paradigm Change

By Sloan Kenneth Wasdo Scott Rautio Jarkko

Pharmaceutical Research, Vol. 23, Iss. 12, 2006-12 ,pp. : 2729-2747

Springer Publishing Company

Access to resources Recommend Favorite

Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy

Current Pharmaceutical Design, Vol. 23, Iss. 16, 2017-06 ,pp. : 2366-2376

Bentham Science Publishers

Access to resources Recommend Favorite